NIRSEVIMAB for Immunisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where NIRSEVIMAB was used for Immunisation.
Most Reported Side Effects for NIRSEVIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Respiratory syncytial virus bronchiolitis | 87 | 35.2% | 0 | 57 |
| Drug ineffective | 65 | 26.3% | 0 | 53 |
| Respiratory syncytial virus infection | 38 | 15.4% | 0 | 38 |
| Cough | 19 | 7.7% | 0 | 16 |
| Pyrexia | 15 | 6.1% | 0 | 10 |
| Apnoea | 14 | 5.7% | 0 | 6 |
| Bronchiolitis | 14 | 5.7% | 1 | 11 |
| Wheezing | 13 | 5.3% | 0 | 7 |
| Incorrect dose administered | 12 | 4.9% | 0 | 3 |
| Syringe issue | 11 | 4.5% | 0 | 0 |
| Enteral nutrition | 9 | 3.6% | 0 | 9 |
| Bradycardia | 8 | 3.2% | 1 | 6 |
| Hypoxia | 7 | 2.8% | 0 | 7 |
| Respiratory syncytial virus test positive | 7 | 2.8% | 0 | 4 |
| Rhinitis | 7 | 2.8% | 0 | 7 |
Other Indications for NIRSEVIMAB
Respiratory syncytial virus immunisation (56)
Antiviral prophylaxis (27)
Prophylaxis (9)
Product used for unknown indication (7)
Respiratory syncytial virus bronchiolitis (7)
Other Drugs Used for Immunisation
INFLUENZA VIRUS VACCINE (560)
PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281)
COVID-19 VACCINE NOS (269)
TOZINAMERAN (207)
MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152)
TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148)
PNEUMOCOCCAL VACCINE POLYVALENT (140)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123)
AD26.COV2.S (113)
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)